Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Revenue

Aquestive Therapeutics had revenue of $10.00M in the quarter ending June 30, 2025, a decrease of -50.23%. This brings the company's revenue in the last twelve months to $44.13M, down -24.38% year-over-year. In the year 2024, Aquestive Therapeutics had annual revenue of $57.56M with 13.80% growth.

• Revenue (ttm): $44.13M
• Revenue Growth: -24.38%
• P/S Ratio: 8.44
• Revenue / Employee: $310,789
• Employees: 142
• Market Cap: 612.13M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	57.56M	6.98M	13.80%
Dec 31, 2023	50.58M	2.90M	6.09%
Dec 31, 2022	47.68M	-3.15M	-6.20%
Dec 31, 2021	50.83M	4.98M	10.87%
Dec 31, 2020	45.85M	-6.76M	-12.85%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.